Insight

A patient's blood held potent virus-neutralizing antibodies, but the field's standard method found none of them. Reading the antibodies directly from that same sample delivered multiple potent candidates. Here's an accessible look at our latest proof-of-concept, and why it matters for antibody discovery.

How can we unlock the full potential of human antibodies hidden in complex biological samples? Building on our previous articles about Abvion's founding mission and the power of protein-level antibody discovery , I'm excited to share the technical backbone that makes it all possible. My name is Sem Tamara, and I'm Head of Discovery Technologies at Abvion. With a PhD from Prof Albert Heck's lab at Utrecht University, our company's birthplace, I've seen firsthand how mass spe

Have you ever wondered why some antibody therapies work so well while others fall short? It often comes down to how we find and select them. In this article, we'll explain why protein-level discovery is a breakthrough for Abvion and the field of antibody therapeutics.

What if we could harness the human body’s own defenses to solve the toughest diseases? In this first article on the Abvion blog, we'll explore the scientific foundation of our biotech spin-off and its mission to realize a paradigm shift in human antibody discovery.